GlobeNewswire 05-27 BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
GlobeNewswire 05-13 Immatics Announces First Quarter 2025 Financial Results and Business Update
GlobeNewswire 05-12 Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 05-08 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 05-05 BioNTech Announces First Quarter 2025 Financial Results and Corporate Update
GlobeNewswire 05-05 BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer
GlobeNewswire 05-02 Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administrat...
GlobeNewswire 04-24 BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Pr...
GlobeNewswire 04-22 BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
GlobeNewswire 04-15 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
GlobeNewswire 04-08 Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
GlobeNewswire 03-24 Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Busine...
GlobeNewswire 03-22 Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
GlobeNewswire 03-10 Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
GlobeNewswire 03-10 BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
GlobeNewswire 02-24 BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March...
GlobeNewswire 02-12 Genmab Publishes 2024 Annual Report
GlobeNewswire 02-03 BioNTech Completes Acquisition of Biotheus
GlobeNewswire 2024-08-30 HOOKIPA Pharma Announces Board of Directors Changes
GlobeNewswire 2024-08-22 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 2024-08-19 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire 2024-08-16 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 2024-08-13 Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 2024-08-08 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 2024-08-08 Genmab Updates 2024 Financial Guidance